Condition: Social Anxiety Disorder (SAD) · Sponsor: Newleos Therapeutics, Inc.
The primary goal of this Phase 2 clinical trial is to determine the effects of a novel V1a receptor antagonist (NTX-1472) in adults with Social Anxiety Disorder (SAD). The main questions this trial aims to answer are: * Is NTX-1472 safe and well tolerated in adults with SAD? * How effectively does NTX-1472 treat adults with SAD? Researchers will compare the effects of NTX-1472 with matching placebo (a look-alike capsule that contains no drug). Participants will: * Take NTX-1472 or matching placebo every day for 8 weeks * Visit the clinic 6 times over the course of 14 weeks for checkups and tests
This description comes directly from the study's public registry record.
Newleos Therapeutics Clinical Trial Team · 978-780-5937 · clinicaltrials@newleos.com
Always discuss trial participation with your own doctor first.
| SOAR Clinical Study Site | Encino, California, United States | Recruiting |
| SOAR Clinical Study Site | Los Angeles, California, United States | Recruiting |
| SOAR Clinical Study Site | Oceanside, California, United States | Recruiting |
| SOAR Clinical Study Site | San Jose, California, United States | Recruiting |
| SOAR Clinical Study Site | Jacksonville, Florida, United States | Recruiting |
| SOAR Clinical Study Site | Tampa, Florida, United States | Recruiting |
| SOAR Clinical Study Site | Boston, Massachusetts, United States | Recruiting |
| SOAR Clinical Study Site | Las Vegas, Nevada, United States | Active Not Recruiting |
| SOAR Clinical Study Site | Brooklyn, New York, United States | Recruiting |
| SOAR Clinical Study Site | Memphis, Tennessee, United States | Recruiting |
| SOAR Clinical Study Site | Austin, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07323784